Physician profile
Patrick K Huynh
NPI 1245761303
$17,303.85
in general payments reported to CMS, 2019-2025
41 companies · $5,539 in 2025
The $5,539 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $374 · 2021: $926 · 2022: $688 · 2023: $4,322 · 2024: $5,456 · 2025: $5,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $3,542 · Travel and Lodging: $710 · Entertainment: $13.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,050.00 |
| Food and Beverage | $3,542.07 |
| Travel and Lodging | $710.30 |
| Entertainment | $13.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13,230.48 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $1,010.27 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $464.71 | 2020-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $326.78 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $275.88 | 2023-2025 | |
| Pfizer INC. | $176.04 | 2020-2025 | |
| Lilly USA, LLC | $174.84 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $164.43 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2, Eterna |
| Dexcom, INC. | $141.54 | 2021-2023 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $125.83 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.02 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $106.34 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.13 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $75.67 | 2020-2025 | Capvaxive, Gardasil 9, Belsomra |
| Otsuka America Pharmaceutical, INC. | $68.81 | 2023 | Rexulti |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $67.50 | 2021-2023 | |
| Astellas Pharma US INC | $63.53 | 2025 | Veozah |
| Exact Sciences Corporation | $62.12 | 2023-2024 | Cologuard Collection Kit |
| Agios Pharmaceuticals, INC. | $59.01 | 2024-2025 | Pyrukynd |
| Lucid Diagnostics INC. | $44.00 | 2025 | |
| Eisai INC. | $39.45 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $38.40 | 2022-2024 | |
| Upsher-Smith Laboratories LLC | $33.86 | 2021-2022 | |
| Horizon Therapeutics Plc | $32.96 | 2023 | Krystexxa |
| Inspire Medical Systems, INC. | $32.53 | 2025 | Inspire |
| Boston Scientific Corporation | $29.55 | 2025 | Wavewriter Alpha Prime 16 |
| Edwards Lifesciences Corporation | $27.40 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Echosens North America, INC. | $19.95 | 2025 | Fibroscan |
| Neurocrine Biosciences, INC. | $19.60 | 2024 | Ingrezza |
| Arbor Pharmaceuticals, INC. | $18.66 | 2020 | |
| Idorsia Pharmaceuticals US INC | $18.54 | 2023 | Quviviq |
| Medtronic, INC. | $18.18 | 2025 | Interstim |
| Teva Pharmaceuticals USA, INC. | $17.61 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.90 | 2022 | |
| Philips North America LLC | $14.76 | 2024 | (Ck7) Extended Holter |
| Sanofi Pasteur INC. | $14.44 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.04 | 2024 | Xifaxan |
| Corcept Therapeutics | $14.04 | 2024 | Korlym |
| Optos, INC. | $13.94 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Theracosbio, LLC | $13.41 | 2024 | Brenzavvy |
| Phathom Pharmaceuticals, INC. | $5.70 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Huynh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.